← Eichor
Condition: Epithelioid Sarcoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Epithelioid Sarcoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)
Phase N/A · 22 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT06408441Ph 2 Elacestrant in ER Positive Uterine Sarcomas
Phase 2 · 1 location(s) · Dana-Farber Cancer Institute · NCT07467772Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care
Phase N/A · 8 location(s) · Kantonsspital Winterthur KSW · NCT04300257Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the
NA · 20 location(s) · Institut Claudius Regaud · NCT03967834Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
Phase N/A · 1 location(s) · Dana-Farber Cancer Institute · NCT07675967Ivonescimab in the Treatment of Multiple Advanced Tumors
Phase 2 · 1 location(s) · Fudan University · NCT06683846NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and S
Phase 1/Phase 2 · 7 location(s) · St. Jude Children's Research Hospital · NCT06239272Cardiac Angiosarcoma International Registry
Phase N/A · 1 location(s) · Immune Oncology Research Institute · NCT06715579Evaluate the Safety and Clinical Activity of HH2853
Phase 1/Phase 2 · 25 location(s) · Haihe Biopharma Co., Ltd. · NCT04390737Phase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient Malignancies
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06444880A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07089992An Observational Study on Epithelioid Sarcoma
Phase N/A · 11 location(s) · Italian Sarcoma Group · NCT03099681MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
Phase 2 · 1 location(s) · HRYZ Biotech Co. · NCT06277154Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Phase 1/Phase 2 · 1 location(s) · University of Florida · NCT06625190
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.